Anúncio
Anúncio
BRNS
Barinthus Biotherapeutics plc - ADR
0.76
USDPatrocinado
0.00
+0.28%
09 de jan., 12:28 UTC -5
Encerrado
Pós-Mercado
0.74
-0.02
-2.24%
Relatórios de Lucros BRNS
Rácio de surpresa positiva
BRNS separação 12 de 19 últimas estimativas.
63%
Próximo Relatório
Data do Próximo Relatório
18 de mar. de 2026
Estimate for Q4 25 (Revenue/ EPS)
--
/-$0.40
Mudanças implicadas de Q3 25 (Revenue/ EPS)
--
/+66.67%
Mudanças implicadas de Q4 24 (Revenue/ EPS)
--
/-21.57%
Barinthus Biotherapeutics plc - ADR earnings per share and revenue
On 07 de nov. de 2025, BRNS reported earnings of -0.24 USD per share (EPS) for Q3 25, beating the estimate of -0.45 USD, resulting in a 47.71% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a -10.08% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 4 analistas forecast an EPS of -0.40 USD, with revenue projected to reach -- USD, implying an aumentar of 66.67% EPS, and aumentar of 0.00% in Revenue from the last quarter.
FAQ
What were Barinthus Biotherapeutics plc - ADR's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Barinthus Biotherapeutics plc - ADR reported EPS of -$0.24, beating estimates by 47.71%, and revenue of $0.00, 0% as expectations.
How did the market react to Barinthus Biotherapeutics plc - ADR's Q3 2025 earnings?
The stock price moved down -10.08%, changed from $1.19 before the earnings release to $1.07 the day after.
When is Barinthus Biotherapeutics plc - ADR expected to report next?
The next earning report is scheduled for 18 de mar. de 2026.
What are the forecasts for Barinthus Biotherapeutics plc - ADR's next earnings report?
Based on 4
analistas, Barinthus Biotherapeutics plc - ADR is expected to report EPS of -$0.40 and revenue of -- for Q4 2025.
Which companies are reporting earnings today?
Verificar FXEmpire's Earnings Calendar for today's list of reporting companies.
Anúncio